146 Liver disease outcomes in people with cystic fibrosis after 2 years of elexacaftor/tezacaftor/ivacaftor—results from the RECOVER trialElizabeth Fitzpatrick, P. McNally, Rachel Cregan et al.|Journal of Cystic Fibrosis|2024Cited by 0